FGF2 Overrides TGFβ1-Driven Integrin ITGA11 Expression in Human Dermal Fibroblasts

Area of Science:

• Cell Biology
• Tissue Engineering
• Dermatology

Background:

• Scar formation is a common outcome of soft tissue wound healing due to extracellular matrix deposition by fibroblasts.
• Modulating the wound environment, specifically low oxygen and fibroblast growth factor 2 (FGF2) supplementation, can promote tissue regeneration over scarring.
• Fibroblast growth factor 2 (FGF2) and low oxygen conditions significantly alter gene expression in fibroblasts, particularly for extracellular matrix and adhesion molecules.

Purpose of the Study:

• To investigate the mechanism by which FGF2 and low oxygen conditions down-regulate integrin alpha-11 (ITGA11) in dermal fibroblasts.
• To understand the role of ITGA11 deregulation in fibroblast phenotype modulation during wound healing.
• To explore the interplay between FGF2, TGF-beta1, and ITGA11 expression in the context of wound healing.

Main Methods:

• Reverse transcription polymerase chain reaction (RT-PCR) and quantitative RT-PCR (qRT-PCR) to assess ITGA11 gene expression.
• Western blotting to analyze protein levels of ITGA11.
• Immunocytochemistry to visualize ITGA11 localization within focal adhesions.
• Pharmacological inhibition of signaling pathways (ERK1/2, TGF-beta1).

Main Results:

• Low oxygen conditions combined with FGF2 significantly down-regulated ITGA11 expression in dermal fibroblasts.
• The decrease in ITGA11 was accompanied by its dissociation from focal adhesions.
• FGF2-induced ERK1/2 activity was essential for the loss of ITGA11.
• Transforming growth factor beta 1 (TGF-beta1), a known ITGA11 activator, could not rescue ITGA11 expression in the presence of FGF2.

Conclusions:

• FGF2, under low oxygen, actively suppresses ITGA11 expression in dermal fibroblasts, potentially contributing to a pro-regenerative or anti-fibrotic phenotype.
• The observed down-regulation of ITGA11 by FGF2 overrides the pro-fibrotic signaling typically induced by TGF-beta1.
• These findings suggest a novel mechanism by which FGF2 can redirect fibroblast behavior away from scar formation and towards tissue regeneration.